Max India Limited (MAXIND) reports Q2FY'27 with revenue up 89% YoY, EBITDA loss down 55% YoY, and strong growth in Residences and Care Homes.
Neuland Laboratories Limited (NEULANDLAB) reports Q2 FY27 standalone revenue of ₹457.2 Cr, down 11.4% YoY.
Hikal Limited (HIKAL) announces Q1 FY27 earnings with ₹434 crore revenue, ₹45 crore EBITDA, and ₹(6) crore PAT.
Kopran Limited (KOPRAN) shares Q2 2026-27 financial results, highlighting revenue growth and operational performance.
Yatharth Hospitals reports strong Q2 FY27 results with revenue up 52% YoY and PAT rising 17%, driven by new hospital contributions.
Emcure Pharmaceuticals Limited (EMCURE) reports a 24.3% YoY operating revenue growth and 29.3% PAT growth in Q2FY27.
Gland Pharma Limited (GLAND) gets USFDA approval for Methylprednisolone Acetate Injectable, a bioequivalent to Pfizer's Depo-Medrol.
Krsnaa Diagnostics Ltd. (NSE: KRSNAA) announced Q2 FY2027 results with highest ever quarterly revenue of Rs 2,710 Mn, up 32% YoY.
Akums Drugs & Pharmaceuticals Ltd (AKUMS) reports 32% revenue growth, 106% EBITDA, and 168% PAT increase in Q2 FY27.
Lupin Limited (LUPIN) secures U.S. FDA approval for Amifampridine Tablets, gaining 180-day shared generic exclusivity.